Concepedia

Author

Stephen D. Rubin

GlaxoSmithKline (United States)

Also Known As

Stephen D. Rubin, Stephen Rubin

28

Publications

8.7K

Citations

15

H-Index

20

Concepts

All Affiliations

GlaxoSmithKline (United States)AstraZeneca (United States)The Christie NHS Foundation TrustResearch Triangle Park FoundationMassachusetts General Hospital
SD

About

Stephen D. Rubin is an author at GlaxoSmithKline (United States) specializing in medicine, oncology, and obstetrics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

1.2K

2

Obstetrics

2

2

377

3

Pathology

2

2

359

4

Cell Biology

1

1

199

5

Endocrinology

1

1

161

Stephen D. Rubin

×

15

Publications

8.7K

Citations

15

H-Index

YearCitations

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

Charles E. Geyer, John Forster, Deborah Lindquist,

New England Journal of Medicine

2006

3.4K

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

Caroline Robert, Bogusława Karaszewska, Jacob Schachter,

New England Journal of Medicine

2014

2.6K

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Nancy U. Lin, Véronique Dièras, Devchand Paul,

Clinical Cancer Research

2009

656

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

Cora N. Sternberg, Robert E. Hawkins, John Wagstaff,

European Journal of Cancer

2013

443

Gemtuzumab ozogamicin for <i>de novo</i> acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial

Juliette Lambert, Cécile Pautas, Christine Terré,

Haematologica

2018

336

Anastrazole and oral contraceptives: a novel treatment for endometriosis

Lisa L. Amsterdam, William L. Gentry, Smeta Jobanputra,

Fertility and Sterility

2005

216

Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer

Kunal S. Taskar, Vinay Rudraraju, Rajendar K. Mittapalli,

Pharmaceutical Research

2011

199

Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial

Erica A. Eugster, Stephen D. Rubin, Edward O. Reiter,

The Journal of Pediatrics

2003

161

Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases

Nancy U. Lin, Wolfgang Eierman, Richard Greil,

Journal of Neuro-Oncology

2011

160

Effects of Aromatase Inhibition in Elderly Men with Low or Borderline-Low Serum Testosterone Levels

Benjamin Z. Leder, Jacqueline L. Rohrer, Stephen D. Rubin,

The Journal of Clinical Endocrinology & Metabolism

2004

147

Page 1